Terms: = Colorectal cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Clinical Outcome
17 results:
1. Spatial resolution of cellular senescence dynamics in human colorectal liver metastasis.
Garbarino O; Lambroia L; Basso G; Marrella V; Franceschini B; Soldani C; Pasqualini F; Giuliano D; Costa G; Peano C; Barbarossa D; Annarita D; Salvati A; Terracciano L; Torzilli G; Donadon M; Faggioli F
Aging Cell; 2023 Jul; 22(7):e13853. PubMed ID: 37157887
[TBL] [Abstract] [Full Text] [Related]
2. A five-year follow up study of stage I-IV of rectal cancer with an emphasis on epidermal growth factor over-expression.
Kozłowska-Geller MA; Lewitowicz P; Głuszek SZ
Pol J Pathol; 2021; 72(2):124-129. PubMed ID: 34706519
[TBL] [Abstract] [Full Text] [Related]
3. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
Naderi A
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
[TBL] [Abstract] [Full Text] [Related]
4. The Interleukin 22 Pathway Interacts with Mutant KRAS to Promote Poor Prognosis in Colon cancer.
McCuaig S; Barras D; Mann EH; Friedrich M; Bullers SJ; Janney A; Garner LC; Domingo E; Koelzer VH; Delorenzi M; Tejpar S; Maughan TS; West NR; Powrie F
Clin Cancer Res; 2020 Aug; 26(16):4313-4325. PubMed ID: 32430479
[TBL] [Abstract] [Full Text] [Related]
5. High expression of Krüppel-like factor 5 is associated with poor prognosis in patients with colorectal cancer.
Takagi Y; Sakai N; Yoshitomi H; Furukawa K; Takayashiki T; Kuboki S; Takano S; Suzuki D; Kagawa S; Mishima T; Nakadai E; Miyauchi H; Matsubara H; Ohtsuka M
Cancer Sci; 2020 Jun; 111(6):2078-2092. PubMed ID: 32279400
[TBL] [Abstract] [Full Text] [Related]
6. Reduced serum miR-98 predicts unfavorable clinical outcome of colorectal cancer.
Wang YG; He Q; Guo SQ; Shi ZZ
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8345-8353. PubMed ID: 31646564
[TBL] [Abstract] [Full Text] [Related]
7. C-myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion.
He X; Tan X; Wang X; Jin H; Liu L; Ma L; Yu H; Fan Z
Tumour Biol; 2014 Dec; 35(12):12181-8. PubMed ID: 25185650
[TBL] [Abstract] [Full Text] [Related]
8. A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients.
Szkandera J; Pichler M; Absenger G; Stotz M; Weissmueller M; Samonigg H; Asslaber M; Lax S; Leitner G; Winder T; Renner W; Gerger A
Clin Cancer Res; 2014 Mar; 20(6):1687-97. PubMed ID: 24470513
[TBL] [Abstract] [Full Text] [Related]
9. The rs6983267 SNP is associated with myc transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
[TBL] [Abstract] [Full Text] [Related]
10. 8q24 cancer risk allele associated with major metastatic risk in inflammatory breast cancer.
Bertucci F; Lagarde A; Ferrari A; Finetti P; Charafe-Jauffret E; Van Laere S; Adelaide J; Viens P; Thomas G; Birnbaum D; Olschwang S
PLoS One; 2012; 7(5):e37943. PubMed ID: 22666420
[TBL] [Abstract] [Full Text] [Related]
11. Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and β-catenin interactions.
Lin YY; Hsu YH; Huang HY; Shann YJ; Huang CY; Wei SC; Chen CL; Jou TS
J Clin Invest; 2012 May; 122(5):1881-94. PubMed ID: 22466651
[TBL] [Abstract] [Full Text] [Related]
12. Wnt-pathway activation in intestinal-type sinonasal adenocarcinoma.
Díaz-Molina JP; Llorente JL; Vivanco B; Martínez-Camblor P; Fresno MF; Pérez-Escuredo J; Álvarez-Marcos C; Hermsen MA
Rhinology; 2011 Dec; 49(5):593-9. PubMed ID: 22125792
[TBL] [Abstract] [Full Text] [Related]
13. ECA39 is a novel distant metastasis-related biomarker in colorectal cancer.
Yoshikawa R; Yanagi H; Shen CS; Fujiwara Y; Noda M; Yagyu T; Gega M; Oshima T; Yamamura T; Okamura H; Nakano Y; Morinaga T; Hashimoto-Tamaoki T
World J Gastroenterol; 2006 Sep; 12(36):5884-9. PubMed ID: 17007058
[TBL] [Abstract] [Full Text] [Related]
14. HER2, TOP2A, CCND1, EGFR and C-myc oncogene amplification in colorectal cancer.
Al-Kuraya K; Novotny H; Bavi P; Siraj AK; Uddin S; Ezzat A; Sanea NA; Al-Dayel F; Al-Mana H; Sheikh SS; Mirlacher M; Tapia C; Simon R; Sauter G; Terracciano L; Tornillo L
J Clin Pathol; 2007 Jul; 60(7):768-72. PubMed ID: 16882699
[TBL] [Abstract] [Full Text] [Related]
15. Differential gene expression profiles and identification of the genes relevant to clinicopathologic factors in colorectal cancer selected by cDNA array method in combination with principal component analysis.
Tsunoda T; Koh Y; Koizumi F; Tsukiyama S; Ueda H; Taguchi F; Yamaue H; Saijo N; Nishio K
Int J Oncol; 2003 Jul; 23(1):49-59. PubMed ID: 12792775
[TBL] [Abstract] [Full Text] [Related]
16. Flow cytometric DNA analysis is useful in detecting multiple genetic alterations in squamous cell carcinoma of the esophagus.
Watanabe M; Kuwano H; Tanaka S; Toh Y; Sadanaga N; Sugimachi K
Cancer; 1999 Jun; 85(11):2322-8. PubMed ID: 10357400
[TBL] [Abstract] [Full Text] [Related]
17. Association of genetic alterations of c-myc, c-fos, and c-Ha-ras proto-oncogenes in colorectal tumors. Frequency and clinical significance.
Nagai MA; Habr-Gama A; Oshima CT; Brentani MM
Dis Colon Rectum; 1992 May; 35(5):444-51. PubMed ID: 1373678
[TBL] [Abstract] [Full Text] [Related]
